Skip to main content
SpringerLink
Log in

Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State

Book cover Diabetes Complications, Comorbidities and Related Disorders

Part of the book series: Endocrinology ((ENDOCR))

  • 540 Accesses

Abstract

Diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) are the two most serious hyperglycemic emergencies in patients with diabetes mellitus. DKA most often occurs in patients with type 1 diabetes, but patients with type 2 diabetes are susceptible to DKA under stressful conditions such as trauma, surgery or infections. HHS is more common in adult and elderly patients with poorly controlled type 2 diabetes. In the U.S., the number of admissions for DKA has increased during the past decade to ∼165,000 cases of each year. The rate of hospitalization for HHS is significantly lower, accounting for < 1% of all diabetes related admissions. DKA and HHS are characterized by insulinopenia and severe hyperglycemia; clinically, these two conditions differ by severity of metabolic acidosis, dehydration, metabolic acidosis and ketonemia. The overall mortality recorded among adults is < 1–2% in patients with DKA and ∼10–15% in patients with HHS. Management objectives for DKA and HHS include restoration of circulatory volume and tissue perfusion; correction of hyperglycemia, ketogenesis and electrolyte imbalance; and identification and treatment of the precipitating event. This review describes the clinical presentation, precipitating causes, diagnosis and acute management of these diabetic emergencies, and of practical strategies for their prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Abramson E, Arky R. Diabetic acidosis with initial hypokalemia. Therapeutic implications. JAMA. 1966;196(5):401–3.

    Article  CAS  PubMed  Google Scholar 

  • Adrogue HJ, Lederer ED, Suki WN, Eknoyan G. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore). 1986;65(3):163–72.

    Article  CAS  Google Scholar 

  • American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics. 2000;105(3 Pt 1):671–80.

    Article  Google Scholar 

  • Ananth J, Parameswaran S, Gunatilake S. Side effects of atypical antipsychotic drugs. Curr Pharm Des. 2004;10(18):2219–29.

    Article  CAS  PubMed  Google Scholar 

  • Arieff AI, Carroll HJ. Hyperosmolar nonketotic coma with hyperglycemia: abnormalities of lipid and carbohydrate metabolism. Metabolism. 1971;20(6):529–38.

    Article  CAS  PubMed  Google Scholar 

  • Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V. New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch Intern Med. 1999;159(19):2317–22.

    Article  CAS  PubMed  Google Scholar 

  • Banerji MA, Chaiken RL, Huey H, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes. 1994;43(6):741–5.

    Article  CAS  PubMed  Google Scholar 

  • Banerji MA, Chaiken RL, Lebovitz HE. Prolongation of near-normoglycemic remission in black NIDDM subjects with chronic low-dose sulfonylurea treatment. Diabetes. 1995;44(4):466–70.

    Article  CAS  PubMed  Google Scholar 

  • Bas VN, Uytun S, Torun YA. Diabetic euglycemic ketoacidosis in newly diagnosed type 1 diabetes mellitus during Ramadan fasting. J Pediatr Endocrinol Metab. 2015;28(3–4):333–5.

    PubMed  Google Scholar 

  • Basu A, Close CF, Jenkins D, Krentz AJ, Nattrass M, Wright AD. Persisting mortality in diabetic ketoacidosis. Diabet Med. 1993;10(3):282–4.

    Article  CAS  PubMed  Google Scholar 

  • Beigelman PM. Potassium in severe diabetic ketoacidosis. Am J Med. 1973;54(4):419–20.

    Article  CAS  PubMed  Google Scholar 

  • Ben Salem C, Fathallah N, Hmouda H, Bouraoui K. Drug-induced hypoglycaemia: an update. Drug Saf. 2011;34(1):21–45.

    Article  CAS  PubMed  Google Scholar 

  • Bhowmick SK, Levens KL, Rettig KR. Hyperosmolar hyperglycemic crisis: an acute life-threatening event in children and adolescents with type 2 diabetes mellitus. Endocr Pract. 2005;11(1):23–9.

    Article  PubMed  Google Scholar 

  • Buse JB, Cavazzoni P, Hornbuckle K, Hutchins D, Breier A, Jovanovic L. A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States. J Clin Epidemiol. 2003;56(2):164–70.

    Article  PubMed  Google Scholar 

  • Cahill GF Jr. Fuel metabolism in starvation. Annu Rev Nutr. 2006;26:1–22.

    Article  CAS  PubMed  Google Scholar 

  • Caro JJ, Ward A, Levinton C, Robinson K. The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis. J Clin Psychiatry. 2002;63(12):1135–9.

    Article  CAS  PubMed  Google Scholar 

  • Centers for Disease Control and Prevention, Department of Health and Human Services: Diabetes Data & Trends. Crude and Age-Adjusted Hospital Discharge Rates for Diabetic Ketoacidosis as First-Listed Diagnosis per 1,000 Diabetic Population, United States. 1988–2009. http://www.cdc.gov/diabetes/statistics/dkafirst/. Accessed 1/2013.

  • Centers for Disease Control and Prevention. Mortality due to Hyperglycemic crises. http://www.cdc.gov/diabetes/statistics/complications_national.htm. 2013. Accessed on 2 Sept 2016.

  • Chaudhuri A, Umpierrez GE. Oxidative stress and inflammation in hyperglycemic crises and resolution with insulin: implications for the acute and chronic complications of hyperglycemia. J Diabetes Complicat. 2012;26(4):257–8.

    Article  PubMed  PubMed Central  Google Scholar 

  • Davis SN, Umpierrez GE. Diabetic ketoacidosis in type 2 diabetes mellitus – pathophysiology and clinical presentation. Nat Clin Pract Endocrinol Metab. 2007;3(11):730–1.

    Article  PubMed  Google Scholar 

  • Deeb A, Yousef H, Abdelrahman L, et al. Implementation of a diabetes educator care model to reduce paediatric admission for diabetic ketoacidosis. J Diabetes Res. 2016;2016:3917806.

    Article  PubMed  PubMed Central  Google Scholar 

  • DeFronzo RA, Matzuda M, Barret E. Diabetic ketoacidosis: a combined metabolic-nephrologic approach to therapy. Diabetes Rev. 1994;2:209–38.

    Google Scholar 

  • Ennis ED, Stahl EJVB, Kreisberg RA. The hyperosmolar hyperglycemic syndrome. Diabetes Rev. 1994;2:115–26.

    Google Scholar 

  • Erondu N, Desai M, Ways K, Meininger G. Diabetic ketoacidosis and related events in the Canagliflozin type 2 diabetes clinical program. Diabetes Care. 2015;38(9):1680–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ersoz HO, Ukinc K, Kose M, et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. Int J Clin Pract. 2006;60(4):429–33.

    Article  CAS  PubMed  Google Scholar 

  • Fadini GP, de Kreutzenberg SV, Rigato M, et al. Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. Diabetes Res Clin Pract. 2011;94(2):172–9.

    Article  PubMed  Google Scholar 

  • Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab. 1983;57(1):177–80.

    Article  CAS  PubMed  Google Scholar 

  • Foster DW, McGarry JD. The metabolic derangements and treatment of diabetic ketoacidosis. N Engl J Med. 1983;309(3):159–69.

    Article  CAS  PubMed  Google Scholar 

  • Fulop M. Alcoholism, ketoacidosis, and lactic acidosis. Diabetes Metab Rev. 1989;5(4):365–78.

    Article  CAS  PubMed  Google Scholar 

  • Garg SK, Walker AJ, Hoff HK, D’Souza AO, Gottlieb PA, Chase HP. Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump. Diabetes Technol Ther. 2004;6(1):9–15.

    Article  CAS  PubMed  Google Scholar 

  • Gerich JE, Martin MM, Recant L. Clinical and metabolic characteristics of hyperosmolar nonketotic coma. Diabetes. 1971;20(4):228–38.

    Article  CAS  PubMed  Google Scholar 

  • Gerich JE, Lorenzi M, Bier DM, et al. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin. J Clin Invest. 1976;57(4):875–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gianfrancesco F, Grogg A, Mahmoud R, Wang RH, Meletiche D. Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders. Clin Ther. 2003;25(4):1150–71.

    Article  CAS  PubMed  Google Scholar 

  • Green SM, Rothrock SG, Ho JD, et al. Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis. Ann Emerg Med. 1998;31(1):41–8.

    Article  CAS  PubMed  Google Scholar 

  • Guo RX, Yang LZ, Li LX, Zhao XP. Diabetic ketoacidosis in pregnancy tends to occur at lower blood glucose levels: case-control study and a case report of euglycemic diabetic ketoacidosis in pregnancy. J Obstet Gynaecol Res. 2008;34(3):324–30.

    Article  CAS  PubMed  Google Scholar 

  • Diabetes Control and Complications Trial (DCCT). Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care. 1995;18(3):361–76.

    Article  Google Scholar 

  • Jefferies CA, Nakhla M, Derraik JG, Gunn AJ, Daneman D, Cutfield WS. Preventing diabetic ketoacidosis. Pediatr Clin N Am. 2015;62(4):857–71.

    Article  Google Scholar 

  • Jenkins D, Close CF, Krentz AJ, Nattrass M, Wright AD. Euglycaemic diabetic ketoacidosis: does it exist? Acta Diabetol. 1993;30(4):251–3.

    Article  CAS  PubMed  Google Scholar 

  • Johnson SR, Cooper MN, Jones TW, Davis EA. Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study. Diabetologia. 2013;56(11):2392–400.

    Article  CAS  PubMed  Google Scholar 

  • Karoli R, Fatima J, Salman T, Sandhu S, Shankar R. Managing diabetic ketoacidosis in non-intensive care unit setting: role of insulin analogs. Indian J Pharm. 2011;43(4):398–401.

    Article  CAS  Google Scholar 

  • Kibbey RG. SGLT-2 inhibition and glucagon: cause for alarm? Trends Endocrinol Metab. 2015;26(7):337–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim F, Tysseling KA, Rice J, et al. Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. Arterioscler Thromb Vasc Biol. 2005;25(5):989–94.

    Article  CAS  PubMed  Google Scholar 

  • Kitabchi AE. Ketosis-prone diabetes – a new subgroup of patients with atypical type 1 and type 2 diabetes? J Clin Endocrinol Metab. 2003;88(11):5087–9.

    Article  CAS  PubMed  Google Scholar 

  • Kitabchi AE, Wall BM. Diabetic ketoacidosis. Med Clin North Am. 1995;79(1):9–37.

    Article  CAS  PubMed  Google Scholar 

  • Kitabchi AE, Ayyagari V, Guerra SM. The efficacy of low-dose versus conventional therapy of insulin for treatment of diabetic ketoacidosis. Ann Intern Med. 1976;84(6):633–8.

    Article  CAS  PubMed  Google Scholar 

  • Kitabchi AE, Umpierrez GE, Murphy MB, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care. 2001;24(1):131–53.

    Article  CAS  PubMed  Google Scholar 

  • Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Laffel L. Sick-day management in type 1 diabetes. Endocrinol Metab Clin N Am. 2000;29(4): 707–23.

    Article  CAS  Google Scholar 

  • Latif KA, Freire AX, Kitabchi AE, Umpierrez GE, Qureshi N. The use of alkali therapy in severe diabetic ketoacidosis. Diabetes Care. 2002;25(11):2113–4.

    Article  PubMed  Google Scholar 

  • Li J, Huang M, Shen X. The association of oxidative stress and pro-inflammatory cytokines in diabetic patients with hyperglycemic crisis. J Diabetes Complicat. 2014;28(5):662–6.

    Article  PubMed  Google Scholar 

  • Lipscombe LL, Austin PC, Alessi-Severini S, et al. Atypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data. Schizophr Res. 2014;154(1–3):54–60.

    Article  PubMed  Google Scholar 

  • Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA. 2013;310(12):1240–7.

    Article  CAS  PubMed  Google Scholar 

  • Maldonado MR, Chong ER, Oehl MA, Balasubramanyam A. Economic impact of diabetic ketoacidosis in a Multiethnic indigent population: analysis of costs based on the precipitating cause. Diabetes Care. 2003a;26(4):1265–9.

    Article  PubMed  Google Scholar 

  • Maldonado M, Hampe CS, Gaur LK, et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab. 2003b;88(11):5090–8.

    Article  CAS  PubMed  Google Scholar 

  • Maldonado MR, Otiniano ME, Lee R, Rodriguez L, Balasubramanyam A. Ethnic differences in beta-cell functional reserve and clinical features in patients with ketosis-prone diabetes. Diabetes Care. 2003c;26(8):2469.

    Article  PubMed  Google Scholar 

  • Malone ML, Gennis V, Goodwin JS. Characteristics of diabetic ketoacidosis in older versus younger adults. J Am Geriatr Soc. 1992;40(11):1100–4.

    Article  CAS  PubMed  Google Scholar 

  • Mauvais-Jarvis F, Sobngwi E, Porcher R, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes. 2004;53(3):645–53.

    Article  CAS  PubMed  Google Scholar 

  • McDonnell CM, Pedreira CC, Vadamalayan B, Cameron FJ, Werther GA. Diabetic ketoacidosis, hyperosmolarity and hypernatremia: are high-carbohydrate drinks worsening initial presentation? Pediatr Diabetes. 2005;6(2):90–4.

    Article  PubMed  Google Scholar 

  • McFarlane SI, Chaiken RL, Hirsch S, Harrington P, Lebovitz HE, Banerji MA. Near-normoglycaemic remission in African-Americans with type 2 diabetes mellitus is associated with recovery of beta cell function. Diabet Med. 2001;18(1):10–6.

    Article  CAS  PubMed  Google Scholar 

  • McGarry JD. Lilly Lecture 1978. New perspectives in the regulation of ketogenesis. Diabetes. 1979;28(5):517–23.

    Article  CAS  PubMed  Google Scholar 

  • McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem. 1980;49:395–420.

    Article  CAS  PubMed  Google Scholar 

  • McGarry JD, Woeltje KF, Kuwajima M, Foster DW. Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diabetes Metab Rev. 1989;5(3):271–84.

    Article  CAS  PubMed  Google Scholar 

  • Musey VC, Lee JK, Crawford R, Klatka MA, McAdams D, Phillips LS. Diabetes in urban African-Americans. I. Cessation of insulin therapy is the major precipitating cause of diabetic ketoacidosis. Diabetes Care. 1995;18(4):483–9.

    Article  CAS  PubMed  Google Scholar 

  • Pasquel FJ, Umpierrez GE. Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care. 2014;37(11):3124–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015;38(9):1687–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27(3):813–23.

    Article  PubMed  Google Scholar 

  • Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jacobson AM, Cole CF. Insulin omission in women with IDDM. Diabetes Care. 1994;17(10):1178–85.

    Article  CAS  PubMed  Google Scholar 

  • Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med. 2011;50(5):567–75.

    Article  CAS  PubMed  Google Scholar 

  • Randall L, Begovic J, Hudson M, et al. Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabetes Care. 2011;34(9): 1891–6.

    Article  PubMed  PubMed Central  Google Scholar 

  • Rydall AC, Rodin GM, Olmsted MP, Devenyi RG, Daneman D. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med. 1997;336(26):1849–54.

    Article  CAS  PubMed  Google Scholar 

  • Shen T, Braude S. Changes in serum phosphate during treatment of diabetic ketoacidosis: predictive significance of severity of acidosis on presentation. Intern Med J. 2012;42(12):1347–50.

    Article  CAS  PubMed  Google Scholar 

  • Shen XP, Li J, Zou S, Wu HJ, Zhang Y. The relationship between oxidative stress and the levels of serum circulating adhesion molecules in patients with hyperglycemia crises. J Diabetes Complicat. 2012;26(4):291–5.

    Article  PubMed  Google Scholar 

  • Sobngwi E, Gautier JF. Adult-onset idiopathic type I or ketosis-prone type II diabetes: evidence to revisit diabetes classification. Diabetologia. 2002;45(2):283–5.

    Article  CAS  PubMed  Google Scholar 

  • Sobngwi E, Vexiau P, Levy V, et al. Metabolic and immunogenetic prediction of long-term insulin remission in African patients with atypical diabetes. Diabet Med. 2002a;19(10):832–5.

    Article  CAS  PubMed  Google Scholar 

  • Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 2: ketosis-prone atypical diabetes mellitus. Diabetes Metab. 2002b;28(1):5–12.

    PubMed  CAS  Google Scholar 

  • Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004;53(8):2079–86.

    Article  CAS  PubMed  Google Scholar 

  • Stephens JM, Sulway MJ, Watkins PJ. Relationship of blood acetoacetate and 3-hydroxybutyrate in diabetes. Diabetes. 1971;20(7):485–9.

    Article  CAS  PubMed  Google Scholar 

  • Tang H, Li D, Wang T, Zhai S, Song Y. Effect of sodium-glucose cotransporter 2 inhibitors on diabetic ketoacidosis among patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Care. 2016;39(8):e123–4.

    Article  CAS  PubMed  Google Scholar 

  • Taylor SI, Blau JE, Rother KI. Perspective: SGLT2 inhibitors may predispose to ketoacidosis. J Clin Endocrinol Metabol. 2015a. https://doi.org/10.1210/jc.2015-1884.

  • Taylor SI, Blau JE, Rother KI. SGLT2 inhibitors may predispose to ketoacidosis. J Clin Endocrinol Metab. 2015b;100(8):2849–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Umpierrez G, Freire AX. Abdominal pain in patients with hyperglycemic crises. J Crit Care. 2002;17(1):63–7.

    Article  PubMed  Google Scholar 

  • Umpierrez G, Korytkowski M. Diabetic emergencies – ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222–32.

    Article  CAS  PubMed  Google Scholar 

  • Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS. Diabetic ketoacidosis in obese African-Americans. Diabetes. 1995;44(7):790–5.

    Article  CAS  PubMed  Google Scholar 

  • Umpierrez GE, Kelly JP, Navarrete JE, Casals MM, Kitabchi AE. Hyperglycemic crises in urban blacks. Arch Intern Med. 1997a;157(6):669–75.

    Article  CAS  PubMed  Google Scholar 

  • Umpierrez GE, Clark WS, Steen MT. Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises. Diabetes Care. 1997b;20(4):479–83.

    Article  CAS  PubMed  Google Scholar 

  • Umpierrez GE, Woo W, Hagopian WA, et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care. 1999;22(9):1517–23.

    Article  CAS  PubMed  Google Scholar 

  • Umpierrez GE, DiGirolamo M, Tuvlin JA, Isaacs SD, Bhoola SM, Kokko JP. Differences in metabolic and hormonal milieu in diabetic- and alcohol- induced ketoacidosis. J Crit Care. 2000;15(2):52–9.

    Article  CAS  PubMed  Google Scholar 

  • Umpierrez GE, Latif K, Stoever J, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004a;117(5):291–6.

    Article  CAS  PubMed  Google Scholar 

  • Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care. 2004b;27(8):1873–8.

    Article  CAS  PubMed  Google Scholar 

  • Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med. 2006;144(5):350–7.

    Article  PubMed  Google Scholar 

  • Umpierrez GE, Jones S, Smiley D, et al. Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial. Diabetes Care. 2009;32(7): 1164–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vaarala O, Yki-Jarvinen H. Diabetes: should we treat infection or inflammation to prevent T2DM? Nat Rev Endocrinol. 2012;8(6):323–5.

    Article  PubMed  Google Scholar 

  • Vanelli M, Chiari G, Ghizzoni L, Costi G, Giacalone T, Chiarelli F. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care. 1999;22(1):7–9.

    Article  CAS  PubMed  Google Scholar 

  • Vellanki P, Smiley DD, Stefanovski D, et al. Randomized controlled study of metformin and Sitagliptin on long-term Normoglycemia remission in African American patients with Hyperglycemic crises. Diabetes Care. 2016;39(11):1948–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wilson HK, Keuer SP, Lea AS, Boyd AE 3rd, Eknoyan G. Phosphate therapy in diabetic ketoacidosis. Arch Intern Med. 1982;142(3):517–20.

    Article  CAS  PubMed  Google Scholar 

  • Winter RJ, Harris CJ, Phillips LS, Green OC. Diabetic ketoacidosis. Induction of hypocalcemia and hypomagnesemia by phosphate therapy. Am J Med. 1979;67(5):897–900.

    Article  CAS  PubMed  Google Scholar 

  • Wrenn KD, Slovis CM, Minion GE, Rutkowski R. The syndrome of alcoholic ketoacidosis. Am J Med. 1991;91(2):119–28.

    Article  CAS  PubMed  Google Scholar 

  • Yamada K, Nonaka K. Diabetic ketoacidosis in young obese Japanese men. Diabetes Care. 1996;19(6):671.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Endocrinology and Metabolism, Professor of Medicine at Emory University School of Medicine, Atlanta, GA, USA

    Guillermo E. Umpierrez

Authors
  1. Guillermo E. Umpierrez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guillermo E. Umpierrez .

Editor information

Editors and Affiliations

  1. Endocrinology, Diabetes and Metabolism, University of Verona, Verona, Italy

    Enzo Bonora

  2. Diabetes Division, UTHSCSA, San Antonio, Texas, USA

    Ralph DeFronzo

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Umpierrez, G.E. (2018). Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. In: Bonora, E., DeFronzo, R. (eds) Diabetes Complications, Comorbidities and Related Disorders. Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-319-27316-7_21-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27316-7_21-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27316-7

  • Online ISBN: 978-3-319-27316-7

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
    Published:
    07 August 2019

    DOI: https://doi.org/10.1007/978-3-319-27316-7_21-2

  2. Original

    Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
    Published:
    10 March 2018

    DOI: https://doi.org/10.1007/978-3-319-27316-7_21-1

Search

Navigation